IP Library Granted Patent US 7,074,832
Granted Patent B2
US 7,074,832 · App. 10/365,321 · Granted Jul 11, 2006

Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,074,832
App. No.
10/365,321
Granted
Jul 11, 2006
Kind
B2
Abstract

Topical compositions which include urea and an antimicrobial agent, particularly sulfacetamide or metronidazole, are described. Sulfacetamide compositions further including sulfur are also described. Methods for treating dermatological disorders using the compositions are also described.

Claims (13)

1. A topical composition for the treatment of a dermatological disorder selected from the group consisting of acne, seborrhea, ingrown hairs, pseudofolliculitis barbae, and hyperpigmented skin, the composition comprising:

a dermatologically effective amount of sulfacetamide or a salt thereof;

a dermatologically effective amount of urea wherein the amount of urea is effective for the treatment of the dermatological disorder;

a dermatologically effective amount of gamma tocopherol; and

a dermatologically acceptable carrier,

wherein the composition is effective for the treatment of the dermatological disorder and the composition comprises about 1 to about 40% by weight urea.

2. The composition of claim 1 , wherein the composition comprises about 10 to about 20% by weight urea.

3. The composition of claim 1 , wherein the composition comprises about 5 to about 20% by weight urea.

4. The composition of claim 1 , wherein the composition comprises about 0.1 to about 10% by weight of gamma tocopherol.

5. The composition of claim 1 , wherein the composition comprises about 10% by weight sulfacetamide or its sodium salt, and about 3% gamma tocopherol.

6. A topical composition for treatment of dermatological disorders according to claim 1 and further comprising sulfur.

7. The composition of claim 6 , wherein the composition comprises about 1 to about 10% of weight sulfur.

8. The composition of claim 6 , wherein the composition comprises about 5% by weight sulfur.

Assignments (10)
PATENT RELEASE Recorded Mar 20, 2015
From: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
To: FOUGERA PHARMACEUTICALS INC. (F.K.A. NYCOMED US INC.)
Reel/Frame 035233/0381 →
PATENT SECURITY AGREEMENT Recorded Oct 21, 2011
From: FOUGERA PHARMACEUTICALS INC. (F.K.A. NYCOMED US INC.)
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 027103/0716 →
CHANGE OF NAME Recorded Oct 5, 2011
From: NYCOMED US INC.
To: FOUGERA PHARMACEUTICALS INC.
Reel/Frame 027021/0146 →
MERGER Recorded Sep 15, 2008
From: BRADLEY PHARMACEUTICALS, INC.
To: NYCOMED US INC.
Reel/Frame 021561/0442 →
SECURITY AGREEMENT Recorded Feb 27, 2008
From: WACHOVIA BANK, NATIONAL ASSOCIATION
To: BRADLEY PHARMACEUTICALS, INC.
Reel/Frame 020566/0898 →
NOTICE OF GRANT OF SECURITY INTEREST Recorded Jan 30, 2008
From: BRADLEY PHARMACEUTICALS, INC.
To: WACHOVIA BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 020431/0325 →
NOTICE OF GRANT OF SECURITY INTEREST Recorded Jan 3, 2006
From: BRADLEY PHARMACEUTICALS, INC.
To: WACHOVIA BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 016976/0403 →
NOTICE OF GRANT OF SECURITY INTEREST Recorded Nov 15, 2004
From: BRADLEY PHARMACEUTICALS, INC.
To: WACHOVIA BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 015355/0622 →
NOTICE OF GRANT OF SECURITY INTEREST Recorded Sep 28, 2004
From: BRADLEY PHARMACEUTICALS, INC.
To: WACHOVIA BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 015190/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2003
From: BHAGWAT, DILEEP; GLASSMAN, BRADLEY P.; GLASSMAN, DANIEL
To: BRADLEY PHARMACEUTICALS, INC.
Reel/Frame 014330/0190 →